Bispecific antibodies binding HVEM and CD9
AssigneeUcb Biopharma Srl
InventorsDavid Alan Cook, Helen Margaret Finney, Stephen Edward Rapecki
Life of this patent
Estimating the term…
Abstract
The present invention relates to multispecific antibodies against a novel targets' combination of HVEM and CD9, and their use in the treatment of cancer and infectious diseases.
Claims12
An antibody which comprises a first antigen-binding portion binding HVEM and a second antigen-binding portion binding CD9, wherein the first antigen-binding portion binding HVEM comprises a first heavy chain variable region and a first light chain variable region, wherein the second antigen-binding portion binding CD9 comprises a second heavy chain variable region and a second light chain variable region, and wherein:
- a. the first heavy chain variable region comprises a CDR-H1 comprising SEQ ID NO:
- 3, a CDR-H2 comprising SEQ ID NO:
- 4 and a CDR-H3 comprising SEQ ID NO:
- 5;
- and
- b. the first light chain variable region comprises a CDR-L1 comprising SEQ ID NO:
- 6, a CDR-L2 comprising SEQ ID NO:
- 7 and a CDR-L3 comprising SEQ ID NO:
- 8;
- and
- c. the second heavy chain variable region comprises a CDR-H1 comprising SEQ ID NO:
- 9, a CDR-H2 comprising SEQ ID NO:
- 10 and a CDR-H3 comprising SEQ ID NO:
- 11;
- and
- d. the second light chain variable region comprises a CDR-L1 comprising SEQ ID NO:
- 12, a CDR-L2 comprising SEQ ID NO:
- 13 and a CDR-L3 comprising SEQ ID NO:
- 14.
Dependencies are inferred from the claim text.